VIYASH - Viyash Scientific

Viyash Scientific

VIYASH · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in

Stock Price vs Company Growth

0.9%

2.6%

5.4%

1.0%

15.3%

45.0%

1.2%

10y

8.0%

all

3.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 255 0.9%

241

298

Company Overview

Sales

3,149 Cr

Growth: 25.2%

Profit after Tax

171 Cr

Growth: 24.8%

Mid Cap

11,202 Cr

P/E: 62.3x

Industry P/E: 31.7x

Fundamentals

Sales (Cr)	₹ 3,149
Growth	25.2%
EBITDA	18.9%
P/S	3.6x
Dividend	0.0%
P/E	62.3x
Book Value	₹ 67.7
PEG Ratio	2.5x
ROE	9.2%
P/B	3.8x

Shareholding Pattern

Institutions

Infinity Holdings

5.91 %

Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii

3.35 %

Ashoka India Opportunities Fund

1.35 %

Sbi Healthcare Opportunities Fund

1.21 %

Mukul Mahavir Agrawal

1.05 %

Promoters

Ca Harbor Investments

53.02 %

Chayadeep Ventures Llp

0.27 %

Rajitha Gopalakrishnan

0.2 %

Sajitha Pillai

0.15 %

Vineetha Mohanakumar Pillai

0.12 %

Others

Increase Decrease No change

Company Profile Detailed

Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.

Belongs to (13 Indices) view more

Investors (91)

dilip.sh...

harish.n...

kalpana....

Followers (7)

jose4

joy2

ratnesh2